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Artiﬁcial nucleic acids have the potential to propagate genetic information in vivo purposefully
insulated from the canonical replication and transcription processes of cells. Natural nucleic acids
are synthesized using nucleoside triphosphates as building blocks and polymerases as catalysts,
pyrophosphate functioning as the universal leaving group for DNA and RNA biosynthesis. In order
to avoid entanglement between the propagation of artiﬁcial nucleic acids in vivo and the cellular
information processes, we promote the biosynthesis of natural and xenobiotic nucleic acids (XNA)
dependent on the involvement of leaving groups distinct from pyrophosphate. The feasibility of
such radically novel biochemical systems relies on the systematic exploration of the chemical diver-
sity of nucleic acid leaving groups that can undergo the catalytic mechanism of phosphotransfer in
nucleic acid polymerization. Initial forays in this research area demonstrate the wide acceptance of
polymerases and augur well for in vivo implementation and integration with canonical metabolism.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
The chemical constitution of biopolymers, found in living
organisms, results from the diversity not only of the ‘building
blocks’ i.e. the monomers present in the macromolecules once syn-
thesized, but also from the diversity of the leaving groups used for
activating the monomers (which are absent from the biopolymers
and released during the synthetic process). This ‘backstage scenery’
of biosynthesis has so far not been subjected to a systematic study
to deﬁne the potential for evolving artiﬁcial biodiversity and alter-
native bioprocesses. In the case of nucleic acids, pyrophosphate
(PPi) is a universal leaving group that is released from nucleoside
and deoxynucleoside triphosphates. No exception to the usage ofcal Societies. Published by Elsevier
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(P. Herdewijn), phmarliere@pyrophosphate as leaving group has ever been reported to occur
in any natural cell or virus. This situation contrasts dramatically
with protein biosynthesis, where leaving groups occur as informa-
tional molecules, in the form of tRNAs, whose sequences vary in a
cognate fashion with the chemical structure of the activated amino
acids. Here, we explore the design principles of biochemical leav-
ing groups, review the experimental attempts at diversifying leav-
ing groups in nucleic acid biosynthesis in vitro and propose
scenarios for introducing such alternative leaving groups in vivo.
Introduction of alternative leaving groups (ALG) distinct from
pyrophosphate pertains to both the directed evolution of the natu-
ral nucleic acids RNA and DNA, and to the implementation of an
additional category of nucleic acid in vivo i.e. XNA. The various
conﬁgurations to be tackled from wild type (micro)organisms are
summarized in Table 1.
2. Leaving group (bio) chemistry
Heterolytic cleavage of a molecule gives rise to two fragments,
one of them is called the leaving group. When this leaving group
takes away an electron pair it is called nucleofugal. This process
usually occurs in the presence of an attacking reagent, in this case
a nucleophile. The best leaving groups are the weakest bases, and
protonation increases leaving group potential. This is a very com-
mon reaction in organic chemistry which is usually carried out in
organic solvents. This reaction is also very common in biologyB.V. Open access under CC BY-NC-ND license.
Table 1
Stepwise reassignment of leaving groups to canonical (DNA, RNA) and xenobiotic
(XNA) nucleic acids in genetically reprogrammed living organisms.
Class of organism RNA DNA XNA
0 (wild type) PPi PPi –
I ALG PPi –
II PPi ALG –
III PPi PPi PPi
IV PPi PPi ALG
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leaving groups that can be used, for stability and solubility reasons.
Several leaving groups are used in biology such as thiols (CoASAc),
dialkyl sulphides (S-adenosyl methionin), enolethers (phospho-
enolpyruvate), cyclic ureas (carboxylated biotin), but in most cases
it is a phosphate or a pyrophosphate group (for example in
UDP-glucuronic acid, 30-phosphoadenosine-50-phosphosulfate,
ATP). UDP, for example, is the most common leaving group in
polysaccharide synthesis. In some cases the leaving group may
be a large molecule like tRNA in peptide synthesis. In all events,
however, the leaving group itself is a common metabolite (CoASH,
S-adenosyl homocysteine, pyruvate, biotin, UDP, PAP, ADP, AMP
and so on) that can be reused or further processed. The example
of protein synthesis is interesting, because it is an example where
the leaving group (tRNA) covers information. This is necessary
because during protein synthesis information needs to be trans-
lated from one biopolymer (RNA) to another (protein). tRNA is,
likewise, considered as a crucial molecule in the origin of life and
one can ask the question if the principle of putting information
in the leaving group is not a general approach to exponential
growth and diversiﬁcation of information [1]. Another example
of information transfer during polymerization is that of DNA and
RNA synthesis. In this case, however, there is a direct readout of
information and pyrophosphate functions as the leaving group.
These polymers (nucleic acids and proteins) are central to biologi-
cal studies and their properties and functions have been studied
intensively. However, not much attention has been given to the
potential role of the leaving group in metabolism, information and
energy transfer. These issues become important when considering
the use of artiﬁcial nucleic acids for storing information in a cell
to be used for deﬁned purposes such as the production of therapeu-
tics or coding for a polymer indispensable for the survival of the cell.
3. Enzymatic nucleic acid synthesis
For developing artiﬁcial genes based on synthetic nucleic acids,
one has to realize that in a living cell, many functions are carried
out by similar molecules. The numbers of chemical principles that
are used within a cell are limited. The most striking example is that
of nucleoside triphosphates, characterized by the presence of high
energy phosphoanhydride bonds that drive their chemistry in a
biological context. ATP is involved in information storage and
transfer (ATP as a building block for RNA), in energy transfer
(ATP as an energy carrier to combine molecules), in regulatory
functions (at the level of kinases and signal transduction) and in
driving metabolic pathways (ATP as an activated carrier molecule).
This multifunctionality of nucleoside triphosphates in general, can
be a dangerous trap when trying to replace the natural genetic
system by an artiﬁcial ‘biopolymer’ for deﬁned purposes. Therefore
it is important to dissect the role of nucleoside triphosphates in
building the information system, from their role in other cellular
functions (energy regulation, metabolism), by means of chemical
modiﬁcation. For safety reasons as well as efﬁciency reasons, the
cellular chassis should function independently from the
engineered device.DNA and RNA are synthesized from nucleoside triphosphates. In
this process, one nucleotide is attached (via its 50-phosphate) to the
30-hyroxyl group of the growing nucleic acid chain, using
pyrophosphate as leaving group. The pyrophosphate is further
hydrolyzed to release two phosphate molecules. The nucleoside
triphosphates themselves are synthesized from the monophos-
phates through the action of nucleotide kinases and nucleoside
diphosphate kinases. Because of the many functions of nucleoside
triphosphates, there is ample room for interference with biological
processes when triphosphates of modiﬁed nucleosides are brought
into the cell (a process that is needed for the propagation of artiﬁ-
cial nucleic acids in vivo). Indeed, it would be difﬁcult to install
additional nucleoside triphosphates without interfering with
DNA and RNA metabolism, cell energy supply or substrate-level
phosphorylation.
One way to avoid this intricacy is to use different types of build-
ing blocks for the enzymatic synthesis of the natural nucleic acids
and for the enzymatic synthesis of the artiﬁcial nucleic acids. This
can be realized by substituting the pyrophosphate moiety with
alternative leaving groups in the precursors for the synthesis of
artiﬁcial information systems. Indeed, the chemical structure of
the leaving group can be elaborated leading to segregation of the
polymerization of XNA from that of DNA and RNA and establishing
an informational enclave. Another result, as a consequence, is dis-
entangling the XNA polymerization from the phosphoanhydride
economy of the cell and thus establishing an energetic enclave as
well. In this case, these leaving-group-modiﬁed-nucleotides should
not be accepted as substrate by regular natural polymerases and
vice versa (the evolved polymerase should not accept natural
nucleoside triphosphates as building blocks). The use of alternative
leaving groups would result in genetic enclaves with metabolic
independence, without having to physically separate precursors
of the artiﬁcial nucleic acids from those of DNA and RNA. Indeed,
the implementation of novel leaving groups in metabolism could
overcome the need for physical compartmentalization of unnatural
information transfers and enable the launching and sustaining of
autonomous hereditary procedures in vivo.
The selection of new leaving groups for the enzymatic synthesis
of nucleic acids should be accompanied by a selection of appropri-
ate polymerases, which can use the modiﬁed nucleotides as build-
ing blocks for gene synthesis independent of the cellular gene-
synthesis machinery. The activated nucleotides with alternative
leaving groups should, likewise, not be recognized by other
enzymes involved in cellular functions where nucleoside triphos-
phates play a role. Given the different biochemical mechanisms in-
volved in polymerization, energy supply and metabolic
regulations, this should be within reach. Another prerequisite of
an alternative leaving group is that it is non-toxic. If it corresponds
or could be converted to a common metabolite, it could ﬁt into
recycling pathways, and the accumulation of toxic by-products of
the polymerization process could be prevented.4. Building blocks for XNA synthesis
The ideal properties for such a nucleotide analogue (in vitro and
in vivo) would be: water soluble, chemically and enzymatically
stable, recognized by the active site of polymerases and serve as
substrate for the polymerase; incorporation into the growing
nucleic acid should be a mechanistic-based approach, chain
elongation should occur, the leaving group should be non-toxic
(for example a common cellular metabolite), and the leaving group
should be actively degraded or recycled to make the polymeriza-
tion process irreversible. This mechanistic-based approach is an
important issue as it would imply that a relatively stable molecule
can be used that is converted into a reactive transition state once
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ﬁnd a subtle equilibrium between the potential for enzyme-cata-
lyzed incorporation into nucleic acids and chain elongation to-
gether with the kinetics of these reactions, the enzymatic and
chemical stability of the molecules and the ﬁdelity of the base-
pairing rules.
Many reviews have summarized the different DNA-polymer-
ase families. DNA-dependant DNA-polymerases are subdivided
into six families by sequence homology. However, the polymer-
ization domains of all polymerases share a common architecture
and the general mechanism is similar including: (a) binding DNA
substrate; (b) binding nucleoside triphosphate; (c) conforma-
tional change to form an activated complex; (d) primer exten-
sion by phosphodiester bond formation; (e) conformational
change accompanied by the release of pyrophosphate; (f) trans-
location of the enzyme to the next base in the template, as sum-
marized by Holmberg et al. [2]. Divalent metal ions (typically
Mg2+), coordinated between carboxylate moieties of the enzyme
and phosphate functions of the nucleotides, are involved in the
catalytic process of phosphodiester bond formation between
the 30-OH of the primer and the a-phosphate group of the
incoming nucleotide. Because of this similar mechanism, it can
be expected that the approach may be useful for several poly-
merases, although initial experiments show considerable differ-
ences between HIV-RT, Terminator DNA polymerase, Taq, Vent
(exo-) and KF (exo-) DNA polymerases. However, Since HIV-1
RT shows broad substrate-speciﬁcity, this enzyme was chosen
by us as a primary polymerase for selection of potential leaving
groups as potential pyrophosphate mimics.
The molecular mechanism of the polymerization reaction and
the structural changes involved seems to be conserved between
different polymerases [3]. The active site pocket is created by
conformational changes occurring after binding of the nucleoside
triphosphate. In the case of RT, binding of a dNTP induces sub-
stantial side chain repositioning in the active site, resulting in
a contact between Lys65 and Asp72 with the incoming dNTP
(with the c- and a- phosphate, respectively) and involving the
carboxylate of Asp110 in chelation with the magnesium ion of
the incoming dNTP [3]. However, the interaction between
Lys65 residue of RT and the c-phosphate of the incoming nucle-
otide is not absolutely required for the nucleotidyl transfer reac-
tion [4]. Nucleoside diphosphates may therefore be utilized as
substrate of RT in a single nucleotide incorporation experiment,
but the efﬁciency is very low (km of dADP is 9.9 lM versus
0.02 lM for dATP, kcat of dADP is 0.02 min-1 versus 2.3 min-1
for dATP, a reduction in efﬁciency (kcat/km) by a factor of 50
000). Dinucleoside pyrophosphate can also be used as substrate
for polymerases, likewise with reduced efﬁciency [1]. The nucle-
otidyl transfer seems to be a general acid catalyzed reaction in
which active-site amino acid residues are involved in the proton-
ation of the pyrophosphate leaving group [5]. Two metal ions are
responsible for lowering the pKa of the primer 30-OH group, for
orientation of the nucleoside triphosphate, for the stabilization
of the pentavalent transition state and for the release of pyro-
phosphate [5]. During a cycle of single nucleotide incorporation
two enzyme conformations exist. The translocation itself is in-
duced by the dissociation of pyrophosphate (released by the
phosphoryl transfer reaction) after the nucleotide addition, at
least for T7 RNA polymerase [6]. The conformational changes in-
duced by the pyrophosphate release prevents the 30 terminus
from binding to the N site (product binding), such that only
the P (primer binding) site is available for binding the primer
terminus [6]. The contribution of the pyrophosphate leaving
group to DNA synthesis, in terms of catalytic efﬁciency and ﬁdel-
ity of DNA polymerase b, has been studied. These data suggest a
leaving-group-induced change in the rate limiting step due tostabilization of pyrophosphate elimination [7]. Chemical modiﬁ-
cation of the leaving group inﬂuences active-site structural dif-
ferences between the correct and incorrect base-paired
transition state [8].
Knowing the complexity of the polymerization process, we ex-
pected that it would be a difﬁcult task to discover new leaving
groups with similar properties to pyrophosphate.
As a result, modiﬁcation of the triphosphate moiety of natural
nucleosides with the aim of discovering alternative substrates for
polymerases is a research area that is not well documented. The
reason for the fact that research on triphosphate modiﬁcation of
nucleosides for the enzyme catalyzed polymerization is underde-
veloped is that there is a general belief that it will be difﬁcult to
ﬁnd a chemical substitute for the pyrophosphate moiety of a nucle-
oside triphosphate that has similar leaving group capabilities,
water solubility, and high energy content while still being recog-
nized by polymerase enzymes.
Generally, such modiﬁcations have been investigated in
searching for inhibitors of enzymes such as adenylate cyclase
and reverse transcriptase or as inhibitors of nucleotide binding
receptors. Research on the substrate speciﬁcity of polymerases
is mainly focused on modiﬁcations in the base moiety or the su-
gar moiety of the nucleotides, but seldom in the triphosphate
moiety. The enzymatic synthesis of modiﬁed nucleic acids (phos-
phoramidates) using sugar modiﬁed nucleoside triphosphates
was pioneered by Letsinger [9] using dNTTP as substrate and
DNA polymerase I of Escherichia coli as catalyst. The aim of this
research is to synthesize backbone modiﬁed nucleic acids using
an enzymatic approach. Most information about sugar- and tri-
phosphate- modiﬁed nucleosides and their incorporation into
DNA using enzymes (reverse transcriptase) is available from
the HIV literature (with the goal of ﬁnding potent inhibitors of
HIV replication) [10].
The modiﬁcations that have been investigated so far are mainly
minor modiﬁcations within the triphosphate moiety itself. The
most studied groups have been methylene phosphonate (1a–c),
phosphoramidate (1d, 1g) and thiophosphate analogues of ATP
(2a-c) (Scheme 1, [11–25]). Investigations on the structure of imid-
odiphosphate and methylene diphosphoric acid [26] in comparison
with pyrophosphate reveals that the P  P distance is similar in
these three compounds. An interesting observation is that the
imidodiphosphate linkage occurs naturally [27].
The b,c-methylene analogue (1b) is able to substitute for ATP in
an RNA polymerase reaction [28]. Taq polymerase is able to incor-
porate the Sp-diastereomer of dNTPaS into DNA [29]. ATPaS can be
used as substrate by DNA dependent RNA polymerase from E. coli
[30]. Also, modiﬁcations at the terminal (c) phosphate of the nucle-
oside triphosphate (1e–g) seem to be well accepted by polymer-
ases. For example the ﬂuoro [18], OMe [19] and anilidate [19]
modiﬁed ATP’s (scheme 1) are substrates for DNA-dependent
RNA polymerase of E. coli. 50-P-Borane substituted nucleoside tri-
phosphates (3a) are excellent substrates for Sequence (a modiﬁed
T7 DNA polymerase) [20].
The [a,b-imino] triphosphate analogue of ATP is an effective
substrate for T7 RNA polymerase [31]. The b,c-diﬂuoromethylene
analogue of ATP (1 h) is an improved substrate for E. coli DNA-
dependent RNA polymerase (relative to the methylene analogue)
[21] (Scheme 1). The modiﬁcation of the leaving group in the b,c
position, however, alters efﬁciency and ﬁdelity of the incorporation
reaction using DNA polymerase b [7]. Other phosphonate ana-
logues that have been found to be substrates for polymerases are
phosphonomethoxy’s (1i) [22] and Pa-alkyl phosphonates (3b)
[23–25]. The ﬁrst compound was tested using bacterial DNA-
dependent RNA polymerase, while the second type of compounds
were evaluated as substrates for terminal transferase, HIV-RT,
AMV-RT and DNA polymerase b.
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Scheme 1. Structure of nucleoside triphosphates, chemically modiﬁed in the triphosphate moiety.
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One of the prerequisites for selecting a new leaving group for
the enzymatic polymerization of xeno nucleic acids is that the po-
tential leaving group must be metabolically accessible. Three levels
of metabolic accessibility can be considered e.g. a leaving group
that is a commonmetabolite in all cells (e.g. L-Asp), a leaving group
that is produced by nature in a selected series of organisms (e.g.
phosphono-L-Ala), a leaving group for which a metabolic scheme
can be easily designed based on well-known metabolic reactions
occurring in micro-organisms (e.g. iminodiacetate). We have elab-
orated several examples of these three groups.
The ﬁrst example where the structure of the leaving group of
the nucleoside triphosphate mimic deviates considerably from that
of the natural pyrophosphate moiety while keeping the capacity to
be recognized by polymerases (in casu reverse transcriptase), is
that of L-Asp-dAMP and L-His-dAMP [32] (Scheme 2). It seems thatP
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spatial arrangement of functional groups for the formation of a ter-
tiary complex in the active site of the enzyme. In addition, the
binding of L-Asp-dAMP or L-His-dAMP and catalytic metal ions
allows further rearrangements of the catalytic amino acid residues
and positioning of the 30-OH group of the terminal nucleotide of
the primer, to make the phosphodiester bond formation possible
by cleavage of the aP-N bond. Likewise, L-Asp-dGMP, L-Asp-dCMP
and L-Asp-dTMP are substrates for HIV-RT, while retaining canon-
ical base-pair selectivity [33]. Incorporation of L-His-dAMP by
HIV-1 RT however proceeded with lower efﬁciency than with
L-Asp-dAMP. However in contrast to its congener L-Asp-dAMP, pri-
mer chain elongation was slightly improved when L-His-dAMP
was used. It is important to note that regardless of the phosphor-
amidate mimic, DNA synthesis dramatically slowed down after
incorporation of two nucleotides, for which the biochemical reason
is not clear.O
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accept L-Asp-dAMP as substrate and to elongate the DNA chain by
several nucleotides [34]. On the other hand, glutamate, glycine,
alanine, proline, tyrosine and serine, or the methyl ester of aspar-
tate and histidine were poor substrates for the enzyme. The fact
that L-Glu-dAMP is not recognized as substrate, while L-Asp-dAMP
is recognized, means that the process of recognition and incorpora-
tion is very speciﬁc. Encouraging results, however, are: that the
primer can be extended with up to six deoxyadenosines (although
polymerization starts to stall after incorporation of two to three
nucleotides), that the incorporation reaction follows Watson- Crick
rules and is stereoselective (L- versus D-amino acids), and that the
incorporation of the four building blocks L-Asp-dAMP, L-Asp-dCMP,
L-Asp-dGMP, L-Asp-dTMP) follows Michaelis–Menten kinetics.
An intriguing question is how these alternative leaving groups
are bound in the active site and what the activation mechanism
is. It is difﬁcult to rationally design binding modes for alternative
substrates in the active site of an enzyme while keeping its activa-
tion mechanism for the reaction close to the natural system. Initial
molecular modelling experiments have demonstrated that L-Asp-
dAMP and L-His-dAMP and dTTP might bind in a different way in
the active site of RT, but that similar amino acids are involved
(Arg 72, Lys 65, Asp 110, Asp 185, Asp 186). Both magnesium ions
play a role in the binding of the three substrates. Steady state ki-
netic analysis of L-Asp-dAMP incorporation indicates that Vmax
for incorporation of L-Asp-dAMP in DNA is only threefold lower
than that of an HIV RT natural substrate. The high km value for L-
Asp-dAMP implies weak binding to the polymerase active site. This
suggests fast and efﬁcient nucleophilic displacement of the amino
acid moiety once the amino acid phosphoramidate substrate is
bound in the active site and formation of a phosphodiester bond
has occurred. The speciﬁcity, or a Vmax/km value, for insertion of
amino acids phosphoramidates versus a natural substrate is de-
creased 1300-fold. Similar kinetics is observed for L-Asp-dCMP, L-
Asp-dGMP and L-Asp-dTTP (Table 2). It should be mentioned, how-
ever, that measuring kinetics based on percent gel band extension
per minute gives mostly results for single nucleotide incorporation
that are underestimated, because in this experiment the whole
process is monitored (including conformational changes and DNA
release) [35].
These encouraging results motivated us to further explore new
potential metabolic accessible leaving groups for enzyme-cata-
lyzed DNA synthesis. N-Methyl-L-aspartic acid is as good a leaving
group as L-aspartic acid but with lower base-pair selectivity (A
against C and A against A incorporation) [33]. Efﬁcient incorpora-
tion and chain elongation was also observed for the d-dicarboxybu-
tyl amine leaving group, although the full potential of this system
could not be evaluated because only the cytosine nucleotide was
available (which requires a poly-G template) [36].
The superior leaving group properties of a phosphodiester
(versus a phosphoramidate) was demonstrated by comparing sev-
eral O- and N- linked dAMP analogues. The leaving group efﬁciencyTable 2
Steady-state kinetics of the incorporation of L-Asp-nucleotides in DNA catalyzed by
HIV-RT (polymerase at 0.015 V/lL).
Substrate Vmax [pmol min1 U] KM [lM] Vmax/KM (106)
dATP 8.39 ± 0.82 0.46 ± 0.15 18.1
L-Asp-dAMP 2.63 ± 0.13 185.3 ± 24.55 0.014
dGTP 28.81 ± 1.55 0.54 ± 0.15 53.4
L-Asp-dGMP 2.14 ± 0.13 168.8 ± 27.9 0.013
dTTP 30.82 ± 1.44 0.53 ± 0.07 58.2
L-Asp-dTMP 2.33 ± 0.22 288.2 ± 61.72 0.008
dCTP 5.62 ± 0.80 3.74 ± 0.95 1.5
L-Asp-CMP 0.59 ± 0.04 130.8 ± 19.8 0.005increases in the order b-alanine< b-hydroxypropionic acid < gly-
cine < a-hydroxyacetic acid [37]. When comparing b-imidazole
lactic acid-dAMP (ILA-dAMP) and L-His-dAMP, the former is a bet-
ter substrate. The substrate afﬁnity is doubled and the maximum
velocity is increased by a factor of 10 (Table 3). However, pausing
is also observed here after incorporation of two to three nucleo-
tides, indicating that this effect is not caused by the nature of the
linker (P–O versus P–N) [38].
The inﬂuence of electrostatics has been evaluated by substitut-
ing the b-carboxylic acid of L-Asp-dAMP with a phosphonate group,
giving 3-phosphono-L-Ala-dAMP (Scheme 2) [39]. This is a consid-
erably improved substrate, showing a Vmax which is only 1.3-fold
lower than that of dATP and a km that is 78-fold higher (Table 4).
The Vmax/km ratio is 99 times lower than for dATP. When compared
with L-Asp-dAMP, improved chain elongation has been observed,
but is still less effective than with dATP. The phosphonate group
and the phosphoramidate group seem to mimic the c- and a-phos-
phate groups of deoxynucleotide triphosphates, respectively. The
carboxyl group functions as a mimic of the b-phosphate group.
Among the four bases studied (A, C, T, C), the A, G and T analogues
are good substrates, but C is only incorporated at higher concentra-
tions. The efﬁciency of the leaving group seems to be base-depen-
dent and the Watson–Crick base pairing rules are respected. The
base-dependent effect is not clear, but it is consistent with the
observation that the processive DNA systems using dTTP are less
efﬁcient than using dATP. Stacking interactions may be involved
here [40]. Apparently, 3-phosphono-L-alanine may replace pyro-
phosphate in its elongation function, but less efﬁciently as is clear
from the lower processivity of DNA synthesis. However, when
comparing the efﬁciency of using 3-phosphono-L-Ala-dNMP
(N = A, T, G) as substrates for different enzymes [HIV-RT,
Vent(exo), Therminator polymerase] the DNA-dependent DNA
polymerase activity is signiﬁcantly higher for Vent(exo) polymer-
ase than for HIV-1 RT, and Vent(exo) polymerase is more accurate
than Therminator polymerase, based on Watson–Crick pairing.
Vent(exo) polymerase may synthesize DNA efﬁciently without
stalling effects. The stalling effect seems to be polymerase depen-
dent and, likewise, the optimal pyrophosphate mimic for the en-
zyme catalyzed synthesis of DNA is polymerase dependent [41].
Since we aim to develop cellular systems using orthogonal nu-
cleic acids as information systems in bacterial organisms, it would
be important that the above mentioned modiﬁed nucleotides are
accepted as substrate by selected polymerases of bacterial origin.
PolIII belongs to polymerase family C and it is found in the repli-
some of E. coli at a low density of molecules [42]. Its a-subunit,
which is endowed with polymerase activity, accepts L-Asp-dAMP
as substrate for both single nucleotide incorporation and for chain
elongation. (A. Giraut et al., unpublished results) This polymerase
seems to be an ideal candidate for directed evolution for implant-
ing an orthogonal information system in vivo.
As demonstrated above, the common metabolite aspartate cou-
pled to the phosphate group of deoxynucleotides by a P–N phos-
phoramidate bond provides unnatural adducts acting as
competent substrates in the HIV-1 RT directed template-depen-
dent DNA polymerisation. Through broadening our search of the
chemical space, we addressed the synthesis and enzymatic assay
of the deoxyadenylate adduct of iminodiacetate [43] (Scheme 2).Table 3
Kinetic parameters of the incorporation of dAMP into DNA by HIV-1 RT. Polymerase at
0.0063 U/lL (dATP and ILA-dAMP) or 0.025 U/lL (L-His-dAMP).
Substrate Vmax [pmol min1 U] KM [lM] Vmax/KM (106)
dATP 5.114 ± 0.397 0.48 ± 0.13 10.65
L-His-dAMP 0.330 ± 0.033 505.0 ± 114.8 0.0007
ILA-dAMP 2.746 ± 0.144 204.7 ± 30.8 0.013
Table 4
Steady-state kinetics of single nucleotide incorporation into DNA by HIV-1 RT at
0.0125 U/lL.
Substrate Vmax (nM/
min)
Km (lM) Vmax/Km
(103 min1)
dATP 12.5 ± 0.26 1.01 ± 0.11 12.37
3-Phosphono-L-Ala-
dAMP
9.84 ± 0.26 78.9 ± 6.70 0.125
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substitution pattern of the nitrogen atom of the phosphoramidate
moiety, while taking care of potential chelating properties and
staying focused on potential metabolic accessibility of the new
leaving group. Enhanced coordination of the magnesium ion by
the leaving group moiety of the modiﬁed nucleotide might inﬂu-
ence incorporation kinetics and efﬁciency of the chain elongation
reaction. In addition, iminodiacetic acid can be considered as
potentially prone to catabolism into non-toxic cellular constituents
(i.e. glycine and a two-carbon atom fragment). As a consequence,
this degradation reaction may have an effect on the equilibrium
of the nucleotide incorporation reaction. The iminodiacetate dAMP
phosphoramidate (IDA-dAMP) possesses no chiral centre (ensuring
less stereochemical constraint than for the chiral L-Aspartic acid).
Along with showing better elongation results, IDA-dAMP also
demonstrates somewhat better incorporation kinetics than L-Asp-
dAMP for HIV-1 RT (Table 5). The measured VMax/KM ratio towards
HIV-1 RT is 3 orders of magnitude lower than that of dATP. Simi-
larly to the L-Asp phosphoramidate analogue, the KM of IDA-dAMP
is much higher than for the natural substrate, whereas the VMax is
1.8-fold lower. The increased capacity for chain elongation is par-
alleled by a similar increase in incorporation efﬁciency. It is clear
that enzyme evolution should focus on the selection of a polymer-
ase enhancing KM (rather than VMax) which is easier to achieve than
the inverse.
The observed full-length elongation obtained when using IDA-
dAMP and a purine-elongated template, could be due to the in-
creased afﬁnity of the longer template overhang for the enzyme
and the formation of a more stable tertiary complex. The template
length seems to inﬂuence the ability of HIV-1 RT to recognise and
incorporate an incoming dNTP carrying a modiﬁed leaving group. It
has been shown by Kohlstaedt in 1992 that the template strand
binds to the ﬁngers subdomain of the polymerase active site
[44]. In addition, the binding afﬁnity of RT with DNA duplexes as
template is increased when template overhang was extended by
6 additional bases [45]. From models based on crystal structures
of the complex [45,46], the b3-b4 loop situated in this domain con-
tacts the template three nucleotides upstream from the primer ter-
minus (near or at Leu74). Kew et al. postulated that a stronger
complex between the ﬁngers subdomain of a HIV-RT and the tem-
plate overhang may be responsible for higher processivity by the
enzyme [47]. Another explanation for a decrease in elongation efﬁ-
ciency when using unusual substrates is that the pausing and
strand terminating effect can be sequence selective [48] and/orTable 5
Determination of the kinetic parameters of the incorporation of dAMP with the
natural pyrophosphate leaving group (dATP) the iminodiacetate leaving group (IDA-
dAMP) and the iminodipropionate leaving group into DNA by HIV-1 RT (polymerase
at 0.025 U/lL(a) and at 0.0125 U/lL(b)).
Vmax [nMmin1] KM [lM] Vmax/KM (103 min1)
dATP(a) 24.5 ± 1.1 0.44 ± 0.1 55.7
IDA-dAMP(a) 13.4 ± 1.4 226 ± 61 0.06
dATP(b) 12.4 ± 0.4 0.93 ± 0.1 13.3
IDP-dAMP(b) 11.8 ± 0.5 73.7 ± 9 0.16by the absence of the energetically rewarding hydrolysis of PPi
which could drive the polymerization reaction [49]. Nevertheless,
the appearance of a pausing effect is dependent on the structure
of the leaving group, on the polymerase, and on the concentration
used in the experimental set-up.
Modelling experiments showed us that in the ground state the
carboxylate groups of IDA-dAMP are most likely to be bound to an
intricate network of amino acid residues located in the enzyme’s
active site via divalent cations. This model implies that the stabili-
sation of IDA-dAMP is enhanced and involves 6 amino acid resi-
dues instead of 4 with the natural substrate and 5 with L-Asp-
dAMP. This increase in amino acid interactions observed in the
complex formation with IDA-dAMP is reﬂected in a change in KM.
The electrostatic involvement of residues Gln155A and Asp186A
has not been observed in previous studies. The difference in bind-
ing afﬁnity between pyrophosphate and iminodiacetic acid is likely
to contribute to a difference in kinetics [50].
By synthesizing and evaluating a series of IDA-dAMP analogues,
either bearing an extended aliphatic chain in the amino acid func-
tion, or a phosphonic acid moiety, we observed that iminodiprop-
ionic acid is a leaving group that shows improved kinetics and
elongation ability compared to IDA-dAMP (Table 5) [51]. When
using HIV-1 RT as catalyst, the Vmax of IDP-dAMP is similar to the
natural substrate. However, an increase in the KM value for the
modiﬁed substrate is observed, compared to dAMP. The catalytic
efﬁciency of IDP-dAMP toward HIV-1 RT is therefore only reduced
by 83-fold compared to dAMP.
6. Metabolic accessibility and recycling
A constraint of crucial importance when reprogramming bio-
polymers using unnatural building blocks lies in the import of
xenobiotic molecules into living cells. Passive diffusion would be
insufﬁcient for feeding the biosynthetic ﬂux and active transport
has to be mobilized for this purpose. Five experimental scenarios
can be contemplated according to availability of metabolic en-
zymes and uptake systems (Table 6). In the simplest scenario (A)
the molecules each consisting in a xeno nucleotide activated with
the same alternative leaving group are supplied exogenously to the
cells and transported in the cytoplasm to serve as substrates of a
xeno polymerase. This has the advantage of not involving meta-
bolic enzymes, but implies the discovery or evolution of at least
one transport catalyst, and a heavy burden for the chemically syn-
thesizing complex and fragile activated xeno nucleotides. In the
opposite scenario (E) all xeno nucleotides activated with the alter-
native leaving group are synthesized endogenously by repro-
grammed cells. This entails the daunting task of evolving
numerous metabolic enzymes. Moreover, it would also potentially
create a biohazard, since chemically autonomous cells able to
propagate xeno nucleic acids could be suspected of seeking niches
in natural habitats.
The three remaining scenarios (B, C, D) (see Table 6) potentially
present the least experimental drawbacks and environmental haz-
ards. Accordingly activated xeno nucleotides would be synthesized
by at least one metabolic enzyme, but either the correspondingTable 6
Scenarios of nutritional dependency and metabolic capability in using alternative
nucleic acid leaving groups.
Scenario Nucleos(t)ide Alternative leaving group Activated nucleotide
A – – Uptake
B Uptake Uptake Biosynthesis
C Biosynthesis Uptake Biosynthesis
D Uptake Biosynthesis Biosynthesis
E Biosynthesis Biosynthesis Biosynthesis
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supplied exogenously to reprogrammed cells.
The use of natural amino acids such as aspartate or histidine as
alternative nucleic acids leaving groups are compatible with sce-
narios A, D and E, but since the latter scenario must be avoided,
these amino acids should be conjugated to artiﬁcial nucleotides
that cannot form in known metabolic pathways (scenarios A, B
and D, excluding C and E).
Phosphonoalanine, which does not occur in canonical metabo-
lism, could serve in scenarios A–D. However, it occurs naturally
in the sea anemone Zoanthus sociatus [52] and the protozoan Tetra-
hymena pyriformis [53] and is non-toxic. It could thus be feared
that the enzymes required for synthesis could be spread by hori-
zontal genetic transfer, rendering possible the advent of scenario
E. Phosphonoalanine should therefore be restricted to experimen-
tal scenarios A, B and D, in which the biosynthesis of xeno nucleo-
sides is excluded.
The chemical series of iminodicarboxylate phosphoramidates
i.e. P–N conjugates of the three compounds of structure
HN[(CH2)mCO2H][(CH2)nCO2H] m and n being 1 or 2, offers an
opportunity for extending metabolism so as to encompass novel
nucleic acid leaving groups. Iminodicarboxylates can be endoge-
nously produced from or degraded to the commonmetabolites gly-
cine, glyoxylate, beta-alanine and malonate semialdehyde through
enzymatic reactions related to opine metabolism. Condensation of
cyclotriphosphate with an iminodicarboxylate occurs spontane-
ously at appropriate concentrations and pH producing triphosphoi-
minodicarboxylate (TPI) [54,43]. Putative enzymes capable of
accelerating this spontaneous reaction could possibly be found in
the class of hydrolases that act on acid anhydrides, such as trimeta-
phosphatase (EC 3.6.1.2) [55]. Our study, however, showed that
further condensation of triphosphoimidiacetate with the 50 hydro-
xyl of the nucleoside deoxyadenosine did not proceed spontane-
ously under the various conditions tested [43]. Nevertheless,
since this reaction features the nucleophilic attack of a phosphoan-
hydride by a primary alcohol as performed by many kinases, the
systematic assay of such enzymes could unveil a biocatalyst mar-
ginally endowed with the desired activity.
In the long run, a fully integrated metabolic cycle disentangled
from canonical nucleoside triphosphate could likely be assembled
for reloading xeno nucleosides into activated substrates of a xeno
polymerase.
7. Conclusion
The in vitro exploration of alternative leaving groups in syn-
thetic nucleotides to be subjected to templated enzymatic poly-
merization has enabled the identiﬁcation of numerous and
unsuspected activated chemical constructs that can undergo con-
densation by DNA polymerases. Most of the assays focused on
the substitution of the regular dNTPs by deoxynucleotides acti-
vated with pyrophosphate surrogates of the phosphoroamidate
types. They unveiled a broad tolerance of polymerases toward such
unnatural metabolic precursors of nucleic acids, even though
incorporation was often limited to one to three nucleotides. There
is little doubt that directed evolution will afford mutant polymer-
ases processively catalysing unlimited incorporation of surrogate
dNTPs lacking a pyrophosphate moiety. Such artiﬁcial phylogenies
of polymerases will be pertinent for addressing profound scientiﬁc
questions such as the metabolic conditions for emergence of infor-
mational polymers as well as technological opportunities such as
the tightly controlled propagation of additional classes of nucleic
acids, thus extending the central dogma of molecular biology for
resuming molecular evolution without endangering natural
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